secwatch.observer — SEC 8-K summary
======================================

Issuer:     PTC THERAPEUTICS, INC. (PTCT)
CIK:        0001070081
Form:       8-K
Filed at:   2025-06-17T23:59:59+00:00
Accession:  0001558370-25-008694
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

PTC Therapeutics reports results of 2025 annual meeting; all three proposals approved
--------------------------------------------------------------------------------

- Elected Allan Jacobson (60,386,986 for), David Southwell (59,200,375), Alethia Young (54,894,657) as Class III directors to 2028 term.
- Ratified Ernst & Young as independent auditor for FY 2025: 67,259,475 for, 195,233 against, 21,362 abstained.
- Approved non-binding advisory vote on executive compensation: 60,479,157 for, 1,979,310 against, 44,711 abstained.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1070081/000155837025008694/0001558370-25-008694-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1070081/000155837025008694/tmb-20250617x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-25-008694

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer